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Abstract
Internalization of the pathogenic bacterium Pseudomonas aeruginosa by non-phagocytic cells is promoted by
rearrangements of the actin cytoskeleton, but the host pathways usurped by this bacterium are not clearly understood.
We used RNAi-mediated gene inactivation of ,80 genes known to regulate the actin cytoskeleton in Drosophila S2 cells to
identify host molecules essential for entry of P. aeruginosa. This work revealed Abl tyrosine kinase, the adaptor protein Crk,
the small GTPases Rac1 and Cdc42, and p21-activated kinase as components of a host signaling pathway that leads to
internalization of P. aeruginosa. Using a variety of complementary approaches, we validated the role of this pathway in
mammalian cells. Remarkably, ExoS and ExoT, type III secreted toxins of P. aeruginosa, target this pathway by interfering
with GTPase function and, in the case of ExoT, by abrogating P. aeruginosa–induced Abl-dependent Crk phosphorylation.
Altogether, this work reveals that P. aeruginosa utilizes the Abl pathway for entering host cells and reveals unexpected
complexity by which the P. aeruginosa type III secretion system modulates this internalization pathway. Our results
furthermore demonstrate the applicability of using RNAi screens to identify host signaling cascades usurped by microbial
pathogens that may be potential targets for novel therapies directed against treatment of antibiotic-resistant infections.
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Introduction
Pseudomonas aeruginosa is one of the leading causes of nosocomial
infections in humans. In the setting of pre-existing epithelial tissue
damage and/or host immunocompromise, P. aeruginosa is able to
cause severe infections of the respiratory and urinary tract, skin,
and eye [1]. In addition, P. aeruginosa has a unique ability to cause
chronic infections in the lungs of patients with cystic fibrosis,
leading to end stage lung disease and death [2].
Like many gram-negative pathogens, P. aeruginosa possesses a
type III secretion system (T3SS) that is critical to virulence in vitro
and in vivo [1]. Through this apparatus P. aeruginosa secretes and
translocates into the host cell bacterial effectors that subvert host
cell functions. Four T3SS effectors have been identified in P.
aeruginosa: ExoU is a potent phospholipase that causes rapid host
cell death [3,4]; ExoY is an adenylate cyclase that induces cell
rounding [5]; ExoS and ExoT are highly homologous bifunctional
proteins, with N-terminal GTPase activating protein (GAP)
domains and C-terminal ADP ribosyltransferase (ADPRT)
domains. For both ExoS and ExoT, the GAP domain targets
Rho family GTPases, including Rho, Rac1, and Cdc42 [6–9]. In
contrast, the substrate specificity of the ADPRT domains is distinct
and non-overlapping [10]. While the ExoS ADPRT domain ADP
ribosylates diverse proteins, such as Ras, Ral, Rabs, Rac1, and
Ezrin [11–14], the ADPRT domain of ExoT primarily targets the
SH2 domain of Crk family proteins [15,16]. Together, the
activities of these T3SS effectors are critical for initial colonization
and subsequent acute damage to the mucosal barrier, in part by
causing disruption of the host cell cytoskeleton, breakdown of cell-
cell junctions, and inhibition of wound healing [17–20].
The presence and/or production of T3SS effectors are variable
amongst P. aeruginosa strains and may account for some of the
phenotypic differences observed in different isolates. Indeed,
almost no strain encodes all four effectors [21]. Approximately
25% of P. aeruginosa strains examined thus far encode only ExoU
and ExoT [21]. These strains are cytotoxic and poorly internalized
by epithelial cells, however isogenic mutants lacking these two
effectors more efficiently enter host cells [22]. The remaining 75%
of P. aeruginosa strains produce only ExoS and ExoT, actin-
disrupting toxins that have been shown to cause cell death and
inhibit bacterial internalization [18,23]. Despite the presence of
ExoS and ExoT, these strains are efficiently internalized into
epithelial cells [24]. Taken together, these observations demon-
strate that all strains of P. aeruginosa are capable of entering host
cells, suggesting a fundamental role of invasion in the pathogenesis
of P. aeruginosa infections.
The molecular mechanisms underlying P. aeruginosa invasion
into non-phagocytic cells, such as those that line the mucosal
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barrier, are incompletely understood. P. aeruginosa entry is an actin-
dependent process that involves Rho family GTPases [25]. Recent
studies suggest that Phosphatidylinositol 3-kinase (PI3K) and its
effector Protein kinase B/Akt, which act both upstream and
downstream of Ras and Rho family GTPases [26], are necessary
for and activated upon internalization of P. aeruginosa into Madin
Darby Canine Kidney (MDCK) cells [27]. P. aeruginosa entry also
leads to activation of tyrosine kinases, such as Src [28,29], and
subsequent tyrosine phosphorylation of several host proteins,
including Caveolin [30]. Some strains of P. aeruginosa are
internalized through activation of acid sphingomyelinase and the
release of ceramides in sphingolipid-rich rafts [31]. Reorganization
of these rafts into larger signaling platforms is required for
internalization of bacteria, induction of apoptosis, and the
regulation of the cytokine response in infected cells [31].
While these studies are informative, a comprehensive under-
standing of P. aeruginosa internalization requires more extensive
and far ranging approaches. The use of RNA interference (RNAi)
to rapidly and efficiently inhibit the expression of proteins [32]
affords the possibility of carrying out unbiased forward genetic
screens to identify host proteins critical to P. aeruginosa invasion.
Drosophila melanogaster with its relatively small, non-redundant but
evolutionarily conserved genome, provides an ideal ‘‘genetic’’ host
in which to study host-pathogen interactions. Drosophila readily
takes up double stranded RNA (dsRNA), allowing efficient
inactivation of gene expression in whole flies as well as in
Drosophila tissue culture cell lines. RNAi-based forward genetic
screens in Drosophila S2 cells, a cell line derived from phagocytic
hematopoietic cells [33], have been used successfully to identify
new genes involved in cell division, phagocytosis, and recognition
of bacteria [34–38].
In this study, we establish that P. aeruginosa infection of S2 cells
mimics key aspects of mammalian cell infection including type III
secreted effector-mediated modulation of bacterial entry, suggest-
ing a conserved mode of entry. We used a library of dsRNAs
representing conserved genes involved in the regulation of the
actin cytoskeleton to systematically identify host genes required for
P. aeruginosa uptake in Drosophila S2 cells. Our forward genetic
screen revealed an invasion pathway for P. aeruginosa that involves
Abl tyrosine kinase, its target Crk, the small GTPases Rac1,
Cdc42, and p21-activated kinase (Pak1). We further validated
the role of this signaling cascade in mammalian cells employ-
ing chemical, genetic, and siRNA-based approaches. This
Abl-dependent pathway has not previously been associated with
P. aeruginosa internalization and our studies reveal new complexities
in the modulation of this pathway by the T3SS proteins ExoS and
ExoT. Together our results demonstrate the potential of using
RNAi-based screens to identify host molecules that are important in
the pathogenesis of P. aeruginosa and that may serve as novel drug
targets for treating infections resistant to conventional antibiotics.
Results
RNAi-based screen to identify host factors required for P.
aeruginosa entry
To conduct a functional genomic screen to identify host cell
factors required for internalization of P. aeruginosa, we exploited the
susceptibility of Drosophila S2 cells, a macrophage-like cell line, to
RNAi-mediated gene inactivation. Using a standard aminoglyco-
side protection assay to quantify bacterial internalization, we
initially established that P. aeruginosa invasion of Drosophila S2 cells
mimics entry into mammalian cells by assaying two important
characteristics. First, as with mammalian cells, Cytochalasin D, an
inhibitor of actin polymerization, diminished entry of P. aeruginosa
strain K (PAK) into S2 cells (Figure 1A). PAK encodes the effector
proteins ExoS, ExoT and ExoY, but lacks ExoU. Second, entry of
PAKDSDT, an isogenic strain, in which the ExoS and ExoT genes
have been deleted, into S2 cells was 2–8 fold more efficient than
wild type PAK (Figure 1B); entry of PAKDSDT was also sensitive
to cytochalasin D (data not shown). This finding is consistent with
the known anti-internalization activity of ExoS and ExoT in
mammalian cells [18,24]. These results demonstrate that Dro-
sophila S2 cells recapitulate important aspects of P. aeruginosa entry,
including involvement of the actin cytoskeleton and translocation
and functionality of the two T3SS effectors.
To identify host gene products crucial for the internalization of
P. aeruginosa, we screened a library of dsRNAs representing
phylogenetically conserved genes of Drosophila melanogaster that are
known regulators of the actin cytoskeleton [37]. Given the known
requirement for the actin cytoskeleton in P. aeruginosa invasion, we
reasoned that this approach would yield a high likelihood of
identifying host genes essential to P. aeruginosa invasion.
Drosophila S2 cells were treated with dsRNAs for 4 days and
bacterial invasion assays with PAK were performed in triplicate
three times. Invasion rates were normalized to S2 cell number for
each dsRNA treatment to eliminate any apparent changes in
invasion efficiency secondary to siRNA-mediated changes in cell
number (Table S1 & S2). We chose to further study host proteins
whose depletion reduced invasion by at least 33%, representing
36% of the dsRNAs tested (Table S1). For comparison, we also
tested 23 random dsRNAs from a larger library and found that
only 2 of 23 RNAs (9%) reduced entry (data not shown). These
findings are consistent with our thesis that the subset of genes
involved in regulating the actin cytoskeleton would be enriched for
candidates involved in P. aeruginosa entry.
We predicted that depleting proteins known to directly affect
actin assembly would inhibit P. aeruginosa invasion. Indeed, RNAi-
mediated inactivation of Capping protein beta (Cpb), Kette,
WASP, Sra-1, Abi, SCAR, and the p20 subunit of the Arp2/3
complex reduced invasion (Table S1). We also identified PI3K and
Protein kinase B/Akt, kinases that we have previously shown to be
required for PAK entry into mammalian cells [27]. The
identification of host genes whose depletion is predicted or has
already been shown to modulate internalization confirmed the
validity of this methodology.
Interestingly, our screen identified several components of a
signaling pathway that has not previously been implicated in P.
Author Summary
Mortality from Pseudomonas aeruginosa infections, one of
the leading causes of hospital acquired infections,
approaches 40%, and multiple drug resistant infections
are common and increasing. Internalization of P. aerugi-
nosa by the host cell appears to play a fundamental role in
the pathogenesis of this opportunistic bacterium, but the
host cell factors involved in this process are incompletely
understood. We used a targeted RNAi screen in Drosophila
S2 cells to identify a subset of regulators of the host actin
cytoskeleton that contribute to bacterial entry and
confirmed their involvement in infection of mammalian
cells. We found that P. aeruginosa can modulate this
internalization pathway in a complex manner by injecting
the bacterial toxins ExoS and ExoT into the host cell via its
type III secretion system. The identified host cell molecules
may serve as targets for novel drugs to treat infections
resistant to conventional antibiotics and may be applicable
to a wide range of pathogens.
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aeruginosa invasion, including Abelson tyrosine kinase (Abl), its
target CT10 regulator of Kinase (Crk), and p21-activated kinase
(Pak). The identification of multiple components within a pathway
indicated that this pathway might be relevant to uptake of P.
aeruginosa in host cells. The identification of Abl kinase and its
target protein Crk was even more intriguing as Crk had previously
been shown to be targeted by the P. aeruginosa anti-internalization
factor ExoT [15], although direct demonstration of the role of Crk
in P. aeruginosa entry is lacking. We therefore further investigated
the role of the Abl kinase pathway in the internalization of PAK
into cultured mammalian epithelial cells using pharmacological,
genetic, and biochemical approaches.
Abl tyrosine kinase is required for invasion of P.
aeruginosa in mammalian cells
The Abl family of non-receptor tyrosine kinases consists of two
widely expressed members, Abl and Arg (Abl2) [39,40]. Besides
catalytic and protein-protein-interaction domains, Abl kinases
contain a C-terminal actin-binding domain, a characteristic that is
unique among all known tyrosine kinases. Abl kinases have been
shown to regulate Rac1-dependent cytoskeletal dynamics that
underlie protrusion formation in mammalian cells and have been
implicated in the regulation of a number of cellular processes,
including cell survival, proliferation, adhesion and motility [40].
Using Gleevec (STI571, imatinib), a well-characterized inhibitor
of Abl tyrosine kinase activity [41,42], we preliminarily assessed
the role of Abl kinase in P. aeruginosa invasion into mammalian
cells. Treatment with Gleevec inhibited PAK and PAKDSDT
invasion into mammalian cells to the same extent in a dose-
dependent manner without affecting bacterial adhesion, or host or
bacterial viability (Figure 2A and data not shown). Gleevec did not
inhibit Salmonella typhimurium invasion or adhesion in HeLa cells
(Figure S1A).
As Gleevec is not entirely specific for Abl/Arg kinases [43,44],
we confirmed these results by quantifying the entry of PAK and
PAKDSDT into 3T3 fibroblasts derived from mice lacking both
Abl and Abl-related kinase Arg [39]. Consistent with the known
effects of ExoS and ExoT on bacterial entry into mammalian cells
[18,24], internalization of PAK into 3T3 fibroblasts was about 3.5-
fold less efficient than internalization of PAKDSDT. Furthermore,
entry of either strain in the Abl/Arg deficient cells was decreased
to 60–70% compared to entry into parental cells (Figure 2B). The
absence of Abl kinases did not have an effect on bacterial binding
(data not shown). Entry of S. typhimurium into Abl/Arg depleted
cells was unaffected (Figure S1B). Finally, we demonstrated that
siRNA-mediated depletion of Abl (Figure 2C) decreased invasion
of PAK (data not shown) and PAKDSDT approximately 2-fold
compared to untreated and control siRNA-exposed cells
(Figure 2D), but did not affect adhesion (data not shown).
Collectively, these results indicate that efficient invasion of P.
aeruginosa into mammalian cells requires Abl tyrosine kinase
activity.
Crk is required for P. aeruginosa invasion
Crk is an SH2- and SH3-domain containing adaptor protein
which has been shown to be involved in multiple cellular processes
including phagocytosis, cell adhesion, cell migration, and immune
responses [45]. CrkI and CrkII are splicing variants that differ by
the presence of an additional C-terminal SH3 domain in CrkII
and a tyrosine residue between the two SH3 domains. CrkII is
phosphorylated by Abl kinase at tyrosine 221, resulting in a
conformational change that affects its subcellular localization and
alters its ability to interact with other signaling effectors [46]. CrkI
and II have also been shown to be the major targets of the
ADPRT domain of the effector protein ExoT. ADP-ribosylation of
arginine 20 of the SH2 domain of Crk by ExoT disrupts the
interaction of this domain with binding partners [47]. However, a
direct role for Crk in P. aeruginosa entry has not previously been
demonstrated.
Using RNAi, we tested whether Crk plays a role in P. aeruginosa
entry into mammalian cells. Following depletion of CrkI and CrkII
by dsRNA directed against both isoforms (Figure 3A), invasion of
PAK and PAKDSDT was reduced to 70611% and 5869%,
respectively, compared to bacterial uptake in control RNAi-
treated cells (Figure 3B). CrkI/II depletion had no effect on
adhesion of PAK to host cells (data not shown) or on
internalization of S. typhimurium (Figure S2). Since Crk is a known
target of ExoT, it might have been expected that depletion of Crk
would affect invasion of PAKDSDT to a greater extent than
invasion of the ExoT-expressing wild type strain. Our finding that
invasion of both strains was decreased to similar extents may be
Figure 1. P. aeruginosa entry into Drosophila S2 cells mimics
entry into mammalian cells. (A) Invasion of PAK into Drosoph-
ila S2 cells is actin-dependent. Drosophila S2 cells were treated with
10 mM Cytochalasin D and infected with PAK for 2 h at 28uC. The
number of internalized bacteria was determined by performing an
invasion assay. Results are normalized to untreated cells. ***p,0.001
compared to untreated cells. (B) The T3SS effector proteins ExoS
and ExoT inhibit P. aeruginosa entry into S2 cells. Invasion of PAK
and PAKDSDT into S2 cells after 2 h at 28uC were compared. The results
were normalized with respect to invasion of PAK. ***p,0.001 compared
to invasion of PAK into S2 cells.
doi:10.1371/journal.ppat.1000031.g001
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explained by the observation that the effects of the translocated
effector proteins are only apparent after a delay (see below). The
implication of these results will be discussed later in more detail.
Altogether, our finding that depletion of Crk decreased PAK
invasion into Drosophila S2 cells as well as into mammalian
epithelial cells indicates that Crk is required for P. aeruginosa
invasion and is consistent with the notion that ExoT inhibits
internalization at least in part by disrupting Crk function.
P. aeruginosa induced phosphorylation of CrkII is Abl-
dependent and is required for bacterial internalization
Having shown that Abl kinases and Crk are required for
internalization, we tested Abl kinase activation by assaying CrkII
phosphorylation in response to bacterial infection. Lysates of HeLa
cells infected with PAK and PAKDSDT were immunoblotted with
antibodies that specifically recognize total Crk or CrkII phos-
phorylated on tyrosine 221 (Figures 3C and D). For both PAK and
PAKDSDT, increased CrkII phosphorylation could be detected as
early as 15 minutes post infection. In the case of PAKDSDT, CrkII
phosphorylation increased over time and remained readily
detectable up to 90 minutes post infection (Figure 3C). In contrast,
the fraction of CrkII phosphorylation in PAK-infected cells did not
further increase after 15 minutes and was undetectable by
60 minutes post infection (Figure 3D). These results suggest that
upon binding, P. aeruginosa activates Abl, which leads to CrkII
phosphorylation. Subsequent T3SS-dependent translocation of
ExoS and/or ExoT by the wild type strain PAK inhibits further
CrkII phosphorylation. While both effector proteins exhibit GAP
activity towards Rac1 and Cdc42 [7,8,48], signaling molecules
that are likely downstream of Crk, ExoT is known to directly
Figure 2. P. aeruginosa invasion into mammalian cells is dependent on Abl tyrosine kinases. (A) HeLa cells were infected with PAKDSDT
for 1 h in the presence of the Abl inhibitor Gleevec (0–50 mM), and bacterial invasion was quantified. The results are normalized with respect to
invasion in untreated cells. **p,0.01, ***p,0.001 compared to untreated cells. (B) Abl2/2Arg2/2 fibroblasts and parental 3T3 fibroblasts were
infected with PAK or PAKDSDT for 1 h and bacterial uptake was measured by invasion assays. *p,0.05, ***p,0.001 compared to 3T3 fibroblasts. (C)
HeLa cells were treated with Abl or control (c) siRNA. Cell lysates immunoblotted with an anti-Abl-antibody show decreased Abl protein levels
compared to control siRNA-treated or untreated cells. GAPDH was used as loading control. (D) Standard invasion and adhesion assays were used to
quantify the effect of Abl or control siRNA treatment on invasion and adhesion of PAKDSDT at 1 h into HeLa cells. The results are normalized with
respect to invasion in untreated cells. *p,0.05 compared to control siRNA-treated cells.
doi:10.1371/journal.ppat.1000031.g002
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interfere with Crk function. Indeed, infection with isogenic PAK
mutants lacking either ExoT or ExoS revealed that ExoT was
responsible for the inhibition of PAKDSDT-induced CrkII
phosphorylation (Figure 3E).
To further test whether Abl is responsible for the phosphory-
lation of CrkII upon infection with P. aeruginosa, HeLa cells were
either treated with the Abl kinase inhibitor Gleevec (Figure 3F) or
depleted of Abl by siRNA (Figure 3G). Either treatment abrogated
Figure 3. Abl-dependent Crk phosphorylation is required for P. aeruginosa invasion. (A) HeLa cells were treated with Crk or control (c)
siRNA and cell lysates were immunoblotted with an anti-CrkI/II-antibody. GAPDH was used as loading control. (B) Standard invasion assays were used
to quantify the effect of Crk or control siRNA treatment of invasion of PAK or PAKDSDT at 1 h into HeLa cells. *p,0.05 compared to control RNA-
treated cells. (C–E) HeLa cells were infected with the indicated strains for the indicated times, lysed and immunoblotted with anti-phospho-CrkII-
Y221 and anti-CrkI/II. (F, G) HeLa cells were infected with PAKDSDT for indicated times in the presence of 30 mM Gleevec (F) or after treatment with
Abl or control siRNA (G) and cell lysates were immunoblotted with anti-phospho-CrkII-Y221 and anti-CrkI/II. (H) HeLa cells were transfected with
pCAGGS-CrkII and pCAGGS–CrkII-Y221F for 16 h and cell lysates were immunoblotted with an anti-CrkI/II antibody. GAPDH was used as loading
control. (I) Standard invasion assays were used to quantify the effect of over-expression of CrkII or CrkII-Y221F on invasion of PAKDSDT at 1 h into
HeLa cells. **p,0.01 compared to cells over-expressing wild type CrkII.
doi:10.1371/journal.ppat.1000031.g003
Abl Pathway Is Required for PAK Invasion
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PAKDSDT-induced phosphorylation of CrkII, indicating that Abl
is required for the PAKDSDT induced phosphorylation of CrkII.
We determined whether phosphorylation of CrkII at tyrosine
221 is required for internalization of PAK by examining the effect
of over-expression of either wild type CrkII or a non-phosphor-
ylatable CrkII mutant (CrkII-Y221F; [49]) in HeLa cells on
bacterial internalization. Each protein was over-expressed to
similar levels (Figure 3H). As shown in Figure 3I, over-expression
of CrkII-Y221F resulted in a 34% reduction of the invasion rate of
PAKDSDT compared to invasion in HeLa cells over-expressing
wild type CrkII. Expression of CrkII-Y221F in HeLa cells would
not be expected to completely abolish P. aeruginosa internalization
as these cells still express endogenous CrkII. Nonetheless, these
data demonstrate that phosphorylation of CrkII by Abl kinase is
important for efficient P. aeruginosa internalization.
Rac1 and Cdc42 contribute to internalization of P.
aeruginosa
The Rho family GTPases have previously been linked to Abl
through genetic studies in Drosophila and loss-of-function studies
in mammalian cells [40,50]. In addition, Rac1- dependent
signaling has been shown to be regulated by CrkII, whose ability
to interact with other signaling molecules is modulated upon
phosphorylation [49]. Previous studies demonstrated that Rho-
family GTPase activity is required for internalization of a different
strain of P. aeruginosa, PA103 [25]. Although our initial RNAi
screen suggested only minor effects of Rac1 and Cdc42 on the
entry of PAK into S2 cells (Table S1), RNAi mediated depletion of
either GTPases (Figure 4A) inhibited internalization of PAK into
mammalian cells (Figure 4B). We further tested the effect of Rac1
and Cdc42 depletion on PAKDSDT, PADS and PAKDT. Entry of
PAK, PAKDSDT and PAKDT in Rac1-depleted HeLa cells was
diminished to 6168%, 6765% and 5561% (Figure 4B),
respectively, compared to bacterial entry in control-siRNA treated
cells, while entry of PAKDS was unaffected (90618%). Depletion
of Cdc42 in HeLa cells decreased the entry of PAK, PAKDSDT,
PAKDS and PAKDT to 60613%, 6262%, 71612% and
5961%, respectively (Figure 4B). Bacterial binding was unaffected
(data not shown).
We further examined in detail the kinetics of PAK internali-
zation into epithelial cells. Figure 5 reveals that all four strains
(PAK, PAKDSDT, PAKDT, PAKDS) are equally invasive at early
times of infection, providing a potential explanation for why
depletion of host cell targets of ExoS and ExoT similarly reduced
invasion of PAK and PAKDSDT. The effects of the effector
proteins ExoS and ExoT are only apparent at 30 minutes post
infection. This delay correlates with the kinetics of translocation of
the effector proteins into the host cell cytosol (P. Balachandran,
personal communication). After 30 minutes of infection, only a
limited further increase in the entry of PAK or PAKDS was
observed, suggesting that the anti-internalization activities of ExoT
prevailed. By 1 h post infection, there were 4-fold more
intracellular PAKDSDT than the wild type strain (Figure 5).
Interestingly, PAKDT, the strain that expresses only ExoS, was
even slightly more invasive than PAKDSDT.
We next looked for a correlation between the invasion time
course and activation of Rac1 and Cdc42. ExoS and ExoT are
predicted to have complicated and even opposing effects on Rac1
and Cdc42 activation: both ExoS and ExoT harbor GAP activity
towards Rho, Rac1, and Cdc42 [16], but ADP ribosylation of
Rac1 by ExoS has also been shown to lead to Rac1 activation in
some cell types [51]. Direct correlation of invasion and activation
of these proteins is further complicated by virtue of the fact that we
are examining activation of total cellular Rac1 or Cdc42 whereas
the relevant effect in the host cell could be due to local changes in
concentration or activation. Moreover, as described in the
preceding section, ExoT affects other targets (e.g. CrkII), which
will also impact the overall invasion rate. Nevertheless, we
measured the fraction of activated Rac1 and Cdc42 at various
times after infection with PAK, PAKDSDT, PAKDS or PAKDT.
Between 30 minutes and 1 hour, the time at which the strains
began to show divergent invasion profiles, a slight activation of
Cdc42 is apparent in PAKDS, PAKDT and PAKDSDT relative to
PAK (Figures 4C and D). This finding would be consistent with
both ExoS and ExoT contributing to Cdc42 inhibition through
their respective GAP activities. During this 30 minutes to 1 hour
time frame ExoS apparently promotes activation of Rac1, as PAK
and PAKDT exhibit Rac1 activation, while PAKDS and
PAKDSDT do not (Figures 4E and F).
The following model may account for the observed requirement
for Cdc42 and Rac1 along with the complex changes in total
cellular Cdc42 and Rac1 activation observed over the first hour of
invasion. We propose that PAKDSDT causes local activation and/
or recruitment of Rac1 and Cdc42, resulting in entry into non-
phagocytic cells. PAKDT is reproducibly slightly more invasive
than PAKDSDT at later time points, likely due to the ExoS-
mediated Rac1 activation. Both strains lead to phosphorylation of
CrkII, which, as we demonstrated above, also contributes to
invasion of these strains. PAK, though it shows similar (and also
ExoS-dependent) Rac1 activation relative to PAKDT, is less
invasive, presumably due to ExoT-mediated inhibition of Cdc42
and the ExoT-mediated inhibition of CrkII phosphorylation. Our
observation that PAK activates Rac1 further suggests that the
ADPRT activity of ExoS prevails over the GAP activity of ExoT.
PAKDS does not express ExoS and can therefore not activate
Rac1. In addition, PAKDS is subject to ExoT-mediated inhibition
of Rac1 and Cdc42 (compared to PAKDSDT) as well as ExoT-
mediated inhibition of CrkII phosphorylation. Consequently this
strain shows even less invasion than PAK.
Pak1 is required for P. aeruginosa entry intomammalian cells
Pak1 belongs to a family of serine/threonine kinases and
becomes strongly activated upon binding of activated Rac1 and
Cdc42 to their GTPase binding domain (PBD). Pak1 also plays a
role in growth arrest upon wound closure. Interestingly, this
function is dependent upon the ability of Pak1 and its guanine
exchange factor (GEF) Pix to localize to focal contacts and is
disrupted in both dominant negative and constitutively active
mutants [52]. As shown in Figure 6B, siRNA-mediated depletion
of Pak1 in HeLa cells (Figure 6A) decreased PAKDSDT invasion
approximately 2-fold. Bacterial adhesion was not affected (data not
shown). In addition, simultaneous depletion of Pak1 and Abl
(Figure 6C) did not additively inhibit P. aeruginosa invasion
(Figure 6D), suggesting that Abl kinase and Pak1 function in the
same pathway in P. aeruginosa invasion.
We confirmed these results using MDCK cells that can be
induced to express human Pak1, a kinase-dead mutant of human
Pak1 (Pak1KD; K299R) or a constitutively active Pak1 allele
(Pak1CA; T423E). Figure 6E demonstrates that over-expression of
either the kinase-dead or the constitutively active form of Pak1
inhibits PAKDSDT invasion. The results are consistent with
published reports showing that cycling of Pak1 between its active
and inactive form is critical for its function [52].
Discussion
Understanding how pathogens subvert the host cell cytoskeleton
to induce their own internalization is of great interest, opening
Abl Pathway Is Required for PAK Invasion
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Figure 4. Rac1 and Cdc42 are required for invasion of P. aeruginosa into mammalian cells. (A) HeLa cells were treated with Rac1, Cdc42 or
control (c) siRNA. Cell lysates were immunoblotted with anti-Rac1 and anti-Cdc42, respectively. GAPDH was used as loading control. (B)
Internalization of PAK, PAKDS, PAKDT and PAKDSDT at 1 h was quantified in HeLa cells treated with control siRNA or siRNA against Rac1 or Cdc42.
*p,0.05, **p,0.01 compared to control RNA-treated cells for each bacterial strain. (C–F) GTPase activation assays. HeLa cells were infected with
PAK, PAKDSDT, PAKDS and PAKDT for the indicated times. Lysates were incubated with Pak1-PBD to precipitate GTP-bound Cdc42 and GTP-bound
Rac1. The bound proteins and cell lysates were examined by immunoblotting with anti-Cdc42 (C) and anti-Rac1 (E), respectively. The experiments
were performed 3 times and a typical gel is shown. (D, F) The GTPases activation assays to assess Cdc42 (D) or Rac1 (F) activation upon infection
with PAK, PAKDSDT, PAKDS and PAKDT were quantified by densitometry. Shown are the mean values +/- SD from three independent experiments.
doi:10.1371/journal.ppat.1000031.g004
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new avenues to develop treatments to control antibiotic-resistant
infections as well as furthering our understanding of fundamental
aspects of cell biology. In the experiments reported here, we used
RNAi-mediated gene inactivation in Drosophila S2 cells to carry
out an unbiased forward genetic screen to identify host molecules
crucial to entry of P. aeruginosa. As S2 cells are phagocytic in origin,
our screen had the potential to identify genes involved in
phagocytosis or in pathogen-directed uptake into non-phagocytic
cells. We identified the tyrosine kinase Abl, the adaptor protein
Crk, the Rho family GTPases Rac1 and Cdc42, and Pak as
components of a host signaling pathway which has not previously
been demonstrated to be required for P. aeruginosa entry. Using
comprehensive and complementary approaches, we validated the
role of the Abl kinase pathway in P. aeruginosa entry into
mammalian epithelial cells. Remarkably, three of its components,
Crk, Rac1 and Cdc42, are known targets of ExoS and/or ExoT,
T3SS effector proteins of P. aeruginosa that have been shown to
modulate P. aeruginosa internalization into mammalian cells
[18,24]. Our results further reveal new complexities in the
regulation of bacterial entry by ExoS and ExoT.
Through the use of a chemical inhibitor of Abl kinase, an Abl/
Arg deficient cell line, and RNAi-mediated depletion of Abl, we
demonstrate that this cytoplasmic tyrosine kinase is essential for
efficient internalization of P. aeruginosa by mammalian cells
(Figure 2). Abl kinase has been shown to be a key component of
various steps in the infection of several pathogens, including actin
motility in poxvirus infection, pedestal formation in enterophatho-
genic E. coli, and the entry of Coxsackievirus, and Shigella flexneri
into non-phagocytic cells [50,53–55]. However, the requirement
for Abl in P. aeruginosa internalization does not simply reflect
utilization of a general phagocytic pathway, as Abl is not required
for the phagocytosis of dead bacteria [36]. Likewise, Abl depletion
apparently does not affect the uptake of several other pathogens,
including S. typhimurium (Figure S1), Listeria monocytogenes, Mycobac-
terium fortuitum, and Candida albicans [34,35,38]. Taken together,
these results suggest that a subset of microbial pathogens subvert
Abl-dependent pathways during pathogenesis.
Our data also provide new evidence that Crk plays a role in P.
aeruginosa internalization (Figure 3B), that CrkII is phosphorylated
by Abl upon P. aeruginosa infection (Figures 3C-G), and that the
phosphorylation of CrkII contributes to the internalization of P.
aeruginosa (Figure 3I). The phosphorylation of CrkII at tyrosine
221, which is required for its membrane localization, has been
shown to modulate the ability of this adaptor protein to interact
with other signaling molecules and to regulate the localization of
Rac1 and Rac1-dependent signaling [49]. Phosphorylation of
CrkII has also been demonstrated to be essential for Rac1 and
Cdc42 activation upon Shigella infection [50]. Based on these
findings, we postulate that infection with P. aeruginosa leads to
phosphorylation of CrkII, facilitating its transport to the plasma
membrane, where it interacts with other signaling molecules such
as the small GTPases, eventually leading to bacterial internaliza-
tion. The role of Crk in P. aeruginosa internalization is even more
intriguing as this adaptor protein has been identified as the
substrate for the T3SS effector ExoT [15]. ExoT has been shown
to ADP ribosylate Crk on arginine 20 of its SH2 domain,
disrupting its ability to interact with Paxillin and p130Cas [47].
Our data also suggest that ExoT inhibits CrkII phosphorylation
(Figures 3C–E). Thus, upon translocation of its effector protein
ExoT, P. aeruginosa can downregulate its internalization, at least in
part by disruption of CrkII phosphorylation and function.
This study further reveals that invasion of PAK into epithelial
cells is at least in part a Cdc42 and Rac1 dependent process
(Figure 4B) that is subject to complex regulation. Using isogenic
mutants in ExoS and/or ExoT, we examined the state of Rac1
and Cdc42 activation, the effect of depletion of Rac1 or Cdc42,
and the kinetics of entry to formulate the following model. The
effector deficient strain, PAKDSDT, likely locally activates Rac1
and Cdc42 to enhance entry into non-phagocytic cells, possibly
through the insertion of the T3SS complex. PAKDT, which
translocates ExoS, is even more invasive than PAKDSDT, likely
because of enhanced activation of Rac1 by the ADPRT activity of
ExoS. Our finding that depletion of Rac1 or Cdc42 diminished
entry suggests that there may be local activation of Cdc42 in
addition to the observed ExoS-dependent activation of Rac1.
PAKDS is the least invasive of the four strains, and is least affected
by depletion of Rac1 or Cdc42. This finding suggests that ExoT is
able to effective abrogate Rac1 and Cdc42 activation. Finally, the
phenotype of PAK may be explained as a complex combination of
the synergistic and antagonistic effects of ExoS and ExoT. It is less
invasive than PAKDSDT and PAKDT, likely because the GAP
activity of ExoT partially counteracts the activation of Rac1 by
ExoS.
Previously, our lab reported that ectopic expression of ExoS in
PA103DUDT, a P. aeruginosa strain that does not normally express
ExoS, inhibited internalization into macrophages but variably
inhibited internalization into MDCK cells [18]. These disparate
results are readily explained by reports showing that the ability of
the ADPRT domain of ExoS to activate Rac1 are cell type
specific; Rac1 activation was observed in fibroblasts and epithelial
cells, but not macrophages [51,56]. Our finding that ExoS has a
slight stimulating effect on bacterial internalization into epithelial
cells is particularly remarkable as it might represent a mechanism
that explains why ExoS-expressing strains of P. aeruginosa are more
invasive than strains that do not express ExoS. Furthermore, it
implies that the effect of ExoS on invasion is context (i.e. cell type)
specific. The exact physiological consequence of this remains to be
determined, but it is striking that the vast majority of P. aeruginosa
strains produce both ExoS and ExoT [57]. It is interesting to
speculate that this imparts a flexibility that allows PAK to enter
epithelial cells, such as those that line the mucosal barrier, while
avoiding uptake by macrophages. Alternatively or in addition,
ExoS/ExoT producing strains may exhibit enhanced fitness in the
environment.
Figure 5. Kinetics of internalization of PAK into mammalian
cells. Invasion of PAK, PAKDSDT, PAKDS and PAKDT in HeLa cells at the
indicated times was quantified. Shown are the mean +/2 SD from three
independent experiments.
doi:10.1371/journal.ppat.1000031.g005
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Our work further demonstrates a role for Pak1 in P. aeruginosa
invasion. Pak1 belongs to a family of highly conserved serine/
threonine kinases that are implicated in cytoskeletal rearrangements
induced by GTP-bound forms of Rac1 and Cdc42 [58] (Figure 6).
Interestingly, expression of a constitutively active mutant as well as a
kinase-dead mutant of Pak1 inhibited bacterial internalization
(Figure 6E). These findings corroborate that cycling of this kinase
between an active and inactive state is required for its function [52].
Figure 6. Invasion of P. aeruginosa is Pak1 dependent. (A) HeLa cells were treated with Pak1 or control (c) siRNA. Cell lysates were
immunoblotted with anti-Pak1. GAPDH was used as loading control. (B) Internalization of PAKDSDT at 1 h was quantified in HeLa cells treated with
control siRNA or siRNA against Pak1. *p,0.05 compared to control siRNA-treated cells. (C) HeLa cells were treated with Pak1 and/or Abl siRNA or
control siRNA. Cell lysates immunoblotted with anti-Pak1 and anti-Abl. GAPDH was used as loading control. (D) Internalization of PAKDSDT at 1 h
was quantified in HeLa cells treated with control siRNA or siRNA against Pak1, Abl, and Pak1+Abl. Results are normalized to control siRNA-treated
HeLa cells. *p,0.05, ***p,0.001 compared to control siRNA-treated cells. (E) MDCK cells were induced for 18 h to express human Pak1 (Pak1wt), a
dominant-negative (Pak1DN) or a constitutively active (Pak1CA) mutant of Pak1 by removal of doxycycline. Invasion of PAKDSDT at 1 h was quantified
and the results were normalized with respect to uninduced cells. *p,0.05, ***p,0.001 compared to uninduced cells.
doi:10.1371/journal.ppat.1000031.g006
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Pak1 may facilitate P. aeruginosa invasion by regulating Arp2/3-
dependent actin polymerization. Indeed, the Arp2/3 complex is
also required in P. aeruginosa invasion (Table S1). Pak1 has been
shown to interact both in vivo and in vitro with p41-Arc, a putative
regulatory component of the human Arp2/3 complex [59]. Pak1
phosphorylation of p41-Arc regulates its localization with the
Arp2/3 complex in the cortical nucleation regions of cells [59].
This interaction may represent a mechanism by which the
signaling cascade triggered by P. aeruginosa influences the function
of the Arp2/3-complex, leading to the formation of new actin
filaments and lamellipodia, and eventually to bacterial uptake.
The activation of the Arp2/3 complex is also mediated by the
Wiscott-Aldrich syndrome proteins WASP and WAVE, which are
known effectors of Cdc42 and Rac1, respectively [60,61]. As
RNAi mediated depletion of WASP and WAVE decreased
internalization of P. aeruginosa into S2 cells (Table S1), these
proteins may also be involved in processes leading to bacterial
uptake. This is furthermore supported by the finding that
depletion of Abi, Sra-1 and Kette, which form a complex that
regulates the function of WASP and WAVE in coordinating the
formation of F-actin [61], also affected bacterial internalization
(Table S1). Whether these observations are relevant to non-
phagocytic cells remains to be determined.
Our RNAi screen also identified Phosphatidylinositol 3-kinase
(PI3K) and Protein kinase B/Akt as host molecules that contribute
to efficient P. aeruginosa internalization. Indeed, recent work in our
laboratory demonstrated that PI3K and its downstream effector
Protein kinase B/Akt are required for internalization of PAK in
MDCK cells [27]. It will be important to determine if the PI3K/
Akt pathway intersects with the Abl kinase internalization
pathway. Preliminary results using the pharmacological Abl
inhibitor Gleevec and the PI3K inhibitor LY294002 suggest that
these signaling pathways may be separate (Pielage and Engel,
unpublished data). It is also possible that the interaction between
these two pathways occurs further downstream, such as at the level
of the Rho family GTPases. Alternatively, they may share a
mutual receptor, though further work will be required to elucidate
the details.
As clinically important antibiotic resistance of P. aeruginosa
continues to increase, the identification of host genes essential for
the pathogenesis of P. aeruginosa infections may lead to new drug
targets. The Abl inhibitor Gleevec, a well tolerated drug which has
become a mainstay for the treatment for chronic myelogenous
leukemia and stromal tumors with few side effects [41], has been
shown to protect against vaccinia virus infection in mice [53] and
may prove to be effective against P. aeruginosa and other pathogens
that subvert Abl kinase-dependent pathways. As drugs such as
Gleevec affect host instead of bacterial proteins, they are much less
likely to engender resistance compared to conventional antimi-
crobial treatments, and may be applicable to a wide range of
pathogens. Future studies will be directed towards assessing these
host cell targets as candidates for new therapies.
Materials and Methods
Bacterial strains and cell lines
P. aeruginosa strain K (PAK), PAKDS (ExoS::omega), PAKDT
(ExoT::gent) and PAKDSDT (ExoS::omega, DT::gent) [23] were
routinely grown with vigorous aeration overnight in low salt
(90 mM NaCl) Luria-Bertani (LB) broth at 37uC. Overnight
cultures were diluted 1:30 in LB, grown to a mid-log OD600 and
adjusted to OD600 of 0.1 in cell culture medium.
Salmonella typhimurium SL1344 (obtained from Dr. S. Falkow,
Stanford) was grown overnight without shaking in high salt
(180 mM NaCl) LB broth. Overnight cultures were diluted 1:20 in
cell culture medium and grown to an OD600 of 0.1.
S2 cells (obtained from Dr. R. Vale, UCSF) were cultured in
Schneider’s Drosophila medium (Invitrogen) supplemented with
10% heat-inactivated fetal bovine serum (FBS; HyClone) at 28uC.
HeLa cells (ATCC CCL-2) were routinely grown in minimal
essential medium (MEM, UCSF Cell Culture Facility) supplement-
ed with 10% heat-inactivated FBS. 3T3 cells or 3T3 cells derived
from Abl2/2Arg2/2 mice [39] were grown in Dulbecco’s minimal
essential medium (DMEM; UCSF Cell Culture Facility) supple-
mented with 20% heat-inactivated FBS. MDCK cells expressing
human wild type Pak1, a constitutively active allele (Pak1CA;
T423E) or a kinase-dead allele (Pak1KD; K299R) under control of a
controllable transactivator using the tet-off system [52] were
cultured in DMEM containing 5% FBS and 20 ng/ml doxycycline
(Sigma). To induce expression of the transgene, cells were grown in
the absence of doxycycline. All mammalian cells were maintained at
37uC in a humidified atmosphere containing 5% CO2.
Adhesion and invasion assays
Invasion and adhesion assays were performed as described
previously [62] with minor modifications. 16106 Drosophila S2
cells were seeded into 24-well plates and infected with PAK
growing in exponential phase (multiplicity of infection (MOI) of
30) for 2 h at 28uC. Alternatively, 16105 HeLa cells were seeded
in 24-well plates and incubated overnight. The next day, cells were
infected with exponentially growing bacteria (MOI of 30) for 1 h
(except where noted) at 37uC. For assays performed in the
presence of inhibitors, cells were pre-incubated with medium
containing Cytochalasin D from Zygosporium mansonii (inhibitor of
actin polymerization; 10 mM final concentration; Sigma) or
Gleevec (STI571; selective inhibitor of Abl tyrosine kinase) [41]
at 37uC and 5% CO2 for 1 h prior to the infection. All invasion
and adhesion assays were done in triplicate and error bars indicate
standard errors of the mean (SEM). p values were calculated using
the two-tailed student’s t test.
Transient transfection
46104 HeLa cells were seeded per well of a 24-well-plate. 24 h
later, cells were transfected with pCAGGS-CrkII (wild type Crk
II), pCAGGS-CrkII-Y221F (non-phosphorylatable CrkII mutant)
[49] and pCAGGS (vector only) using Effectene (Qiagen,
Valencia, CA) following the manufacturer’s instructions. After
an incubation period of 16 h, invasion assays were performed and
cells were lysed to check for efficacy of transfection.
RNAi-mediated gene inactivation in Drosophila S2 cells
dsRNAs were generated from a library of DNA templates for 77
genes encoding actin-binding proteins [37] by in vitro transcription
reactions for 6 h at 37uC using RiboMAXTM Large Scale RNA
production system T7 (Promega). 56104 S2 cells were seeded into
96-well-plates, incubated with a final concentration of 10 mg/ml
dsRNA for 4 days and infected with P. aeruginosa (MOI of 30) for
2 h at 28uC following the protocol described above.
Short interfering RNA (siRNA)-mediated protein depletion
siRNAs were purchased from Santa Cruz Biotechnology: Abl
(sc-29843), CrkII (sc-37072), Cdc42 (sc-29256), Rac1 (sc-36351),
Pak1 (sc-29700) and control siRNA (sc-37007). HeLa cells were
transfected with siRNAs according to the manufacturer’s instruc-
tions. After 42 h, standard adhesion and invasion assays were
performed. In parallel, lysates were immunoblotted with appro-
priate antibodies to evaluate the efficiency of protein depletion.
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Preparation of cell lysates and immunoblotting
26106 HeLa cells were seeded onto 10 cm plates, serum-starved
over night, and infected with P. aeruginosa (MOI of 100) for the
indicated times. Cells were washed with PBS and lysed in 1%
Triton X-100 in PBS supplemented with proteinase inhibitors
(Complete; Roche Diagnostics) for 20 minutes at 4uC. Cell lysates
were clarified by centrifugation and separated by SDS-PAGE.
After transfer to PVDF membranes (Immobilon, Millipore),
membranes were blocked in 5% milk in PBS-T (PBS supplement-
ed with 0.1% Tween 20), incubated with primary antibodies
overnight at 4uC, washed in TBS-T buffer (20 mM Tris-HCl,
pH8, 137 mM NaCl, 0.7% Tween 20), incubated with appropri-
ate horseradish peroxidase-conjugated secondary antibodies for
1 h at RT, washed again and developed using a chemilumines-
cence kit (ECL, Amersham Pharmacia).
GTPase activation assay
26106 HeLa cells were seeded onto 10 cm plates and serum-
starved overnight. The next day, cells were infected with P.
aeruginosa (MOI of 100) for the indicated times. To precipitate
GTP-bound Rac1 and Cdc42, cell lysates were incubated with
Pak1-PBD agarose (Rac1/Cdc42 activation assay, Upstate
Biotechnology) following the manufacturer’s instructions. Samples
were run on 12% Bis-Tris gels and immunoblotted as described
above. For quantification GTP-bound Rac1 or Cdc42 was
compared to total Rac1 or Cdc42 and normalized to uninfected
cells.
Antibodies
Antibodies include mouse-anti-c-Abl (sc-23, Santa Cruz Bio-
technology; 1:400), mouse-anti-Crk (BD Transduction Laborato-
ries; 1:2,500), rabbit-anti-phospho-CrkII (Tyr221; Cell Signaling;
1:500), rabbit-anti-Pak1 (N-20; sc-882, Santa Cruz Biotechnology;
1:500), mouse-anti-Rac1 (Upstate Biotechnology; 1:500), rabbit-
anti-Cdc42 (sc-87, Santa Cruz Biotechnology; 1:200), mouse-anti-
GAPDH (Glyceraldehyde-3-phosphate dehydrogenase; MAB374,
Chemicon; 1:20,000), peroxidase-conjugated goat-anti-mouse
(Jackson Immunoresearch; 1:5,000), and peroxidase-conjugated
goat-anti-rabbit (Jackson Immunoresearch; 1:5,000).
Statistics
p values were calculated using the two-tailed student’s t test.
P,0.05 was considered significant.
Supporting Information
Figure S1 S. typhimurium invasion and adhesion to mammalian
cells is independent of Abl tyrosine kinases. A. HeLa cells were
infected with S. typhimurium for 1h in the presence of the Abl
inhibitor Gleevec (0–50 mM), and bacterial invasion and adhesion
was measured at 1 hpi. The results are normalized with respect to
untreated cells. B. Abl/Arg k.o. cells and 3T3 wildtype cells were
infected with S. typhimurium for 1h and bacterial invasion was
measured.
Found at: doi:10.1371/journal.ppat.1000031.s001 (0.16 MB TIF)
Figure S2 S. typhimurium invasion into HeLa cells is independent
of CrkI/II. A. HeLa cells were treated with Crk or control (c)
siRNA. Cell lysates immunoblotted with an anti-CrkI/II-antibody
showed decreased protein levels compared to control siRNA-
treated cells. GAPDH was used as loading control. B. HeLa cells
treated with CrkI/II and control siRNA were infected with S.
typhimurium for 1h and bacterial invasion was measured.
Found at: doi:10.1371/journal.ppat.1000031.s002 (0.23 MB TIF)
Table S1 Host factors that are required for invasion of P.
aeruginosa into S2 cells. RNAi-mediated depletion of the listed
genes decreased P. aeruginosa invasion into S2 cells by at least 33%
compared to invasion into untreated cells. Gene accession
numbers are from Flybase (http://flybase.bio.indiana.edu).
Found at: doi:10.1371/journal.ppat.1000031.s003 (0.06MBDOC)
Table S2 RNAi-mediated depletion of the listed host factors did
not affect P. aeruginosa invasion into S2 cells. RNAi-mediated
depletion of the listed genes did not reduce P. aeruginosa invasion by
more than 32% compared to invasion into untreated cells. Gene
accession numbers are from Flybase (http://flybase.bio.indiana.
edu).
Found at: doi:10.1371/journal.ppat.1000031.s004 (0.08MBDOC)
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